If you have not already registered for Full Text Access to The Journal, then visit our registration page.
Many supplements are available to the general public for a limited time on our SuppleNet page.


VOLUME 60   1999   SUPPLEMENT 12

Articles

3 Introduction. Treatment-Resistant Schizophrenia and Beyond: Current Concepts and Future Prospects.
[PDF]

4 The Evolving Definition of Treatment Resistance. Joseph Peuskens, M.D.
[Abstract] [PDF]

9 Pathophysiologic Mechanisms in the Pathogenesis and Clinical Course of Schizophrenia. Jeffrey A. Lieberman, M.D.
[Abstract] [PDF]

13 Management Strategies for the Treatment of Schizophrenia. John M. Kane, M.D.
[Abstract] [PDF]

18 Some Adverse Effects of Antipsychotics: Prevention and Treatment. Malcolm Lader, M.D.
[Abstract] [PDF]

22 A Historical Perspective of Clozapine. Hanns Hippius, M.D.
[Abstract] [PDF]

24 The Effects of Clozapine on Cognitive Functioning in Schizophrenia. Susan R. McGurk, Ph.D.
[Abstract] [PDF]

30 Clozapine: A Comparison With Other Novel Antipsychotics. W. Wolfgang Fleischhacker, M.D.
[Abstract] [PDF]

35 Optimizing Clozapine Treatment. Dieter Naber, M.D.
[Abstract] [PDF]

39 Clozapine: The Commitment to Patient Safety Larry D. Alphs, M.D., and Ravi Anand, M.D.
[Abstract] [PDF]

43 The Effects of Clozapine on Aggression and Substance Abuse in Schizophrenic Patients. Jan Volavka, M.D.
[Abstract] [PDF]

47 Suicide and Schizophrenia: Clozapine and the InterSePT Study. Herbert Y. Meltzer, M.D.
[Abstract] [PDF]